explore -WSS

explore

author：entertainment 2025-09-06 04:14:25 - browse：2

Mifepristone (Mifeprex) and Misoprostol — A federal appeals court on Wednesday ruled to restrict access to the abortion pill mifepristone but not remove it from the market entirely. ROBYN BECK/AFP via Getty Images

A federal appeals court on Wednesday ruled to restrict access to the abortion pill mifepristone but not remove it from the market entirely, partially upholding a lower court’s decision.

The decision from the three-judge panel of the 5th U.S. Circuit Court of Appeals would effectively block mail-order prescriptions of the pill. However, access will remain unchanged for now, as the Supreme Court issued an emergency order this spring to preserve the status quo while the case goes through the appeals process.

The case is all but assured to head to the highest court, which last year overturned Roe v. Wade. Since the ruling, 14 states have implemented abortion bans and another 11 have imposed limits, some up to six weeks of pregnancy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： A public health expert passes on football's full body collisions for youths

hotspot

focus

WSS

Millions may soon lose Medicaid when they don't have to

Xenotransplantation trials will require adjusting expectations, experts say

Pharma companies must ensure equitable access to obesity drugs

Millions may soon lose Medicaid when they don't have to

My daughter's legacy lives on through her writing, phage therapy

Living organ donors deserve priority status for transplants

focus

explore

knowledge

Moonlake's readout produced a cash windfall. Risks remain

NIH tests clinical research in primary care with $30 million program

Wildfire smoke exposes gaps in outdoor worker protections

Novo: Oral version of Ozempic leads to 15% weight loss

Jerome Adams on the need for new antivirals for Covid

Statins may not be needed by millions of people, study suggests

Novavax promises a turnaround & Lilly roils the obesity market

Can medical device makers keep up in the race to treat obesity?

Sports medicine is finally prioritizing gender equality

Cheap, fast test for Zika and dengue could cost just $1

focus

The system is set up to fail children with medical complexity

Biogen nominates mother of director’s child to replace him on board

Cheap, fast test for Zika and dengue could cost just $1

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Millions may soon lose Medicaid when they don't have to

How faith leaders like me can help address America's obesity epidemic

leisure time

hotspot

focus

knowledge